共 81 条
[21]
Hammers Hans J(2013)Pazopanib versus sunitinib in metastatic renal-cell carcinoma N. Engl. J. Med. 369 917-927
[22]
Donskov Frede(2015)Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: a systematic review and meta-analysis of clinical trials in advanced cancer patients Eur. J. Cancer 51 591-597
[23]
Roth Bruce J(2016)Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial Lancet Oncol. 17 undefined-undefined
[24]
Peltola Katriina(2017)Cabozantinib versus sunitinib as initial targeted therapy for patients with metastatic renal cell carcinoma of poor or intermediate risk: the Alliance A031203 CABOSUN Trial J. Clin. Oncol. 35 undefined-undefined
[25]
Lee Jae Lyun(undefined)undefined undefined undefined undefined-undefined
[26]
Heng Daniel Y C(undefined)undefined undefined undefined undefined-undefined
[27]
Schmidinger Manuela(undefined)undefined undefined undefined undefined-undefined
[28]
Agarwal Neeraj(undefined)undefined undefined undefined undefined-undefined
[29]
Sternberg Cora N(undefined)undefined undefined undefined undefined-undefined
[30]
McDermott David F(undefined)undefined undefined undefined undefined-undefined